Literature DB >> 24343591

Minimally invasive vitreo retinal surgery: how small do we go?

Sundaram Natarajan1.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24343591      PMCID: PMC3959073          DOI: 10.4103/0301-4738.123108

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
The armamentarium of vitreo retinal surgeons has advanced tremendously with advances in physics and now the focus is on the maximum benefit that can be derived using micro incisions. The 23-G and 25-G systems have become fairly common and several studies have been done to determine the safety, advantages and disadvantages of small gauge sutureless surgery.[1] Though higher infusion and aspiration pressures are needed to remove the vitreous using small gauge probes, the corresponding damage on tissues is also substantially lower. My own experience with the small gauge vitrectomy system encouraged me to embrace this advancement in totality. My experience shows that the smaller gauge vitrectomy techniques shorten operating time and improve patient comfort. By minimizing surgically induced trauma, it decreases the post-operative inflammatory response and hastens recovery. Although higher pressures are needed for injection of silicon oil especially the heavy oil, the overall outcomes are much better. Various surgical procedures have been performed with microincision vitrectomy surgery (MIVS) but it is being advocated for macular holes and epiretinal membrane (ERM) surgery. Sandali et al. in their study[2] concluded that in ERM surgery 23-G and 25-G systems are as safe and effective as the 20-G system. They also noted that MIVS systems cause significant reduction in surgical time. Similar results have been reported by Haas et al.[3] I prefer a proportional mode vitrectomy for the separation of the membrane from the retina and it has given me excellent results. Concerns have been raised about the increased risk of endophthalmitis with 23-G and 25-G instrumentation. Oshima et al. in their study Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival MIVS[4] found no significant difference in the incidence of post vitrectomy endophthalmitis between MIVS and 20-G vitrectomy similar results were observed by Bahrani et al.[5] Our experience is also similar as there have been no differences between the 20-G and MIVS in incidence of post-operative endophthalmitis. Nevertheless, the microsurgical task force came up with guidelines for minimizing endophthalmitis with vitrectomy surgery.[6] The advent of the 27-G instrument system, has given a totally new dimension to microsurgery.[7] For obvious reasons the fluid dynamics of the 27-G system are lower than 25-G MIVS. The pros and cons of the small gauge system will have to be weighed to decide how small we can go. The desired goal of surgery is to achieve optimal surgical results with minimal damage. Optimal utilization of the newer properties of machines in relation to the characteristics of the disease will have to be assessed to decide the risk benefit ratio of the MIVS system.[8] The risk of instrument bending, leading to lower stability and reduced cutting efficiency is a point for concern. This needs to be compared with improved wound healing and finer surgical results in select cases. I look at the future where further advances in technology will obviate the risks associated with the smaller gauge.
  8 in total

1.  Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery.

Authors:  Yusuke Oshima; Kazuaki Kadonosono; Hidetaka Yamaji; Makoto Inoue; Munenori Yoshida; Hideya Kimura; Masahito Ohji; Fumio Shiraga; Toshimitsu Hamasaki
Journal:  Am J Ophthalmol       Date:  2010-08-16       Impact factor: 5.258

Review 2.  Endophthalmitis in the era of small gauge transconjunctival sutureless vitrectomy--meta analysis and review of literature.

Authors:  Hasan M Bahrani; Ahad A Fazelat; Mathis Thomas; Tatsuo Hirose; Arnold J Kroll; Peter L Lou; Edward A Ryan
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

3.  25-, 23-, and 20-gauge vitrectomy in epiretinal membrane surgery: a comparative study of 553 cases.

Authors:  Otman Sandali; Mohamed El Sanharawi; Nicolas Lecuen; Pierre-Olivier Barale; Sebastien Bonnel; Elena Basli; Vincent Borderie; Laurent Laroche; Claire Monin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-10       Impact factor: 3.117

Review 4.  Advantages and limitations of small gauge vitrectomy.

Authors:  John T Thompson
Journal:  Surv Ophthalmol       Date:  2011-01-14       Impact factor: 6.048

Review 5.  Perspective on fluid and solid dynamics in different pars plana vitrectomy systems.

Authors:  Octaviano Magalhães; Mauricio Maia; Eduardo B Rodrigues; Leonardo Machado; Elaine F Costa; André Maia; Milton N Moares-Filho; Eduardo Dib; Michel Eid Farah
Journal:  Am J Ophthalmol       Date:  2011-01-19       Impact factor: 5.258

6.  A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.

Authors:  Yusuke Oshima; Taku Wakabayashi; Tatsuhiko Sato; Masahito Ohji; Yasuo Tano
Journal:  Ophthalmology       Date:  2009-10-31       Impact factor: 12.079

Review 7.  The microsurgical safety task force: guidelines for minimizing endophthalmitis with vitrectomy surgery.

Authors:  Rajiv E Shah; Omesh Gupta
Journal:  Curr Opin Ophthalmol       Date:  2012-05       Impact factor: 3.761

8.  Twenty-three-gauge and 20-gauge vitrectomy in epiretinal membrane surgery.

Authors:  Anton Haas; Gerald Seidel; Iris Steinbrugger; Richard Maier; Vanessa Gasser-Steiner; Andreas Wedrich; Martin Weger
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

  8 in total
  1 in total

1.  Single-snip paralimbal incision: A quick approach to rectus muscles.

Authors:  Juhi Saxena; Naheed Akhtar; Yogesh Gupta; Abadan Khan Amitava; Farnaz Kauser; Shiraz Ahmed; S Aisha Raza; Anam Masood
Journal:  Oman J Ophthalmol       Date:  2021-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.